The etiology of MS is not well-understood, but current evidence suggests that activation of myelin-reactive CD4 T cells triggers an inflammatory cascade in the CNS, recruiting other immune cells that mediate the subsequent tissue destruction and pathology (1, 2). Here, CD4 is linked to myeloid sarcoma.